DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award
Funding Amount
$10,080,000 total
Deadline
September 30, 2026
2 days left
Number of Awards
12
Grant Type
Federal
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- Open to all applicant types
Overview
Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Idea Award (TIA) supports new, innovative, high-risk, high-gain ideas aimed at amyotrophic lateral sclerosis (ALS) drug or therapy discovery. The studies supported by this award mechanism are expected to be hypothesis-driven and generate preliminary data for future avenues of therapeutic investigation. Distinctive Features: Potential impact and innovation are important features of the TIA. Applications may demonstrate the ability to achieve interpretable results in the absence of preliminary data supporting the hypothesis. While the inclusion of preliminary data is not prohibited, the strength of the application should rely on the approach.
Details
- Agency: Dept. of the Army -- USAMRAA
- Department: Department of Defense
- Opportunity #: HT942526ALSRPTIA
- Total Funding: $10,080,000
- Expected Awards: 12
- Instrument: grant
Focus Areas & Funding Uses
Fields of Work
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
DoW Breast Cancer, Transformative Breast Cancer Consortium Award
Defense Health Agency Contracting Activity - DHACA
Amount
$35,000,000 total
Deadline
September 30, 2026
DoW Breast Cancer, Breakthrough Award Level 3
Defense Health Agency Contracting Activity - DHACA
Amount
$12,600,000 total
Deadline
September 30, 2026
DoW Amyotrophic Lateral Sclerosis Research Program, Clinical Outcomes and Biomarkers Award
Defense Health Agency Contracting Activity - DHACA
Amount
$7,000,000 total
Deadline
September 30, 2026
DoW Breast Cancer, Breakthrough Award Level 4
Defense Health Agency Contracting Activity - DHACA
Amount
$21,000,000 total
Deadline
September 30, 2026
DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Development Award
Defense Health Agency Contracting Activity - DHACA
Amount
$12,000,000 total
Deadline
September 30, 2026
DoW Amyotrophic Lateral Sclerosis Research Program, Pilot Clinical Trial Award
Defense Health Agency Contracting Activity - DHACA
Amount
$5,600,000 total
Deadline
September 30, 2026
Ready to apply for DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award. Now let's win it.